Pharmacogenomics in Clinical Therapeutics

Pharmacogenomics is the basis of personalized medicine which willbe the medicine of the future. Through both reducing the numbers ofadverse drug reactions and improving the use of existing drugs intargeted populations, pharmacogenomics represents a real advance ontraditional therapeutic drug monitoring. Pharmacogenomics in Clinical Therapeutics provides anintroduction to the principles of pharmacogenomics beforeaddressing the pharmacogenomic aspects of key therapeutic areassuch as warfarin therapy, cancer chemotherapy, therapy withimmunosuppressants, antiretroviral therapy, and psychoactive drugs.It also includes methods of pharmacogenomic testing and thepharmacogenomic aspects of drug-drug interactions. From a team of expert contributors, Pharmacogenomics inClinical Therapeutics is a comprehensive overview of thecurrent state of pharmacogenomics in pharmacotherapy for allclinicians, pharmacologists and clinical laboratory professionals.It is also a guide for practicing clinicians and health careprofessionals to the basic principles of pharmacogenomics,laboratory tests currently available to aid clinicians, and thefuture promise of this developing field.